An intervention trial for patients with substance use disorders using a psychotherapy focused on personality pathology and using therapeutic alliance as a mechanism of change.
Phase 2
- Conditions
- Health Condition 1: F10-F19- Mental and behavioral disorders due to psychoactive substance use
- Registration Number
- CTRI/2022/02/040489
- Lead Sponsor
- ational Institute of Mental Health and Neurosciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
File diagnosis of SUD (mild, moderate, severe) as per DSM-5 and diagnostic criteria
based on assessments (except primary diagnosis of tobacco use disorder)
Ability to comprehend spoken English (minimum education of 7th standard)
Exclusion Criteria
Those under acute intoxication or continuing to have severe withdrawal symptoms
Presence of severe mental disorders such as schizophrenia or major depression with
psychosis at the time of intake.
Presence of acute psychosis at the time of intake.
Presence of any neurological conditions such as frontal lobe syndrome or neuropathy as indicated in file diagnosis.
Intellectual disability (as per file diagnosis)
Having undergone structured psychotherapy in the past one year.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in frequency, intensity and self-efficacy associated with substance use.Timepoint: Pre and Post Intervention and at 1 month follow-up.
- Secondary Outcome Measures
Name Time Method Improvement in Personality and General outcome variablesTimepoint: Pre and Post Intervention and at 1 month follow up